Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: substantially identical with the original patent,shall constitute a continuation

That's the question. It may boil down to whether or not the amendments that were made were semantical or substantive and one would have to be a PhD Microprocessor Engineer to know the difference. Are we at yet another Pandora's box here or is this thing finally coming to a head?

Share
New Message
Please login to post a reply